Amylin Pharmaceuticals Inc. (AMLN)

[trade2much]

Bob... this could be a good play for a while the "expert committee" in the EU recommended approval for this type2 diabetes drug. The regulatory committee has a habit of going with the committee's recommendations and my mid to end Jun we should get an approval imo. If so this should be a big deal for AMLN. Type 2 diabetes patients now have to do injections daily into their stomach etc, this is supposed to make that now weekly if approved. I can't think too many wouldn't opt for this as a result.